The grandfather's fever.
Autoinflammatory diseases
FMF
Genetics
Geriatrics
Periodic fever
Journal
Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
21
03
2019
accepted:
04
08
2019
revised:
23
07
2019
pubmed:
12
8
2019
medline:
20
11
2020
entrez:
12
8
2019
Statut:
ppublish
Résumé
An 86-year-old Caucasian man had prior episodes of fever (up to 38 °C), mild abdominal pain, tachycardia, and malaise in the last 3 months, lasting 2-3 days. He never suffered from abdominal or chest pain, rash, or arthralgia. Major causes of fever were excluded (pulmonary, urinary, abdomen, skin infections, neoplasms, and major rheumatologic disorders). The patient was native of Altamura with a family history of familial Mediterranean fever (FMF). The genetic testing confirmed the presence of MEFV gene variants c.442G>C (E148Q) on exon 2 and c.2282G>A (R761H) on exon 10, all in heterozygosity. Mildly elevated serum transaminases suggested an ongoing form of FMF hepatitis on nonalcoholic liver steatosis. The patient started colchicine 1 mg/day that induced symptom control and normalization of inflammatory markers, hyperbilirubinemia, and markers of cholestasis. Symptoms of FMF can appear at any age in life and our patient represents a very late-onset clinical case. The Apulian region has a consistent clustering of MEFV variants and FMF families with affected individuals in multiple consecutive generations. Families show unique clinical features and rare signs of secondary amyloidosis without kidney damage. Genetic and environmental bases of this phenotypic variant are under scrutiny. Colchicine lifetime remains the mainstay of treatment in FMF patients. KEY POINTS: • Familial Mediterranean fever (FMF) is the most frequent hereditary monogenic recurrent fever syndrome, and symptoms can appear at any age in life. • Late-onset FMF approaches 30% in late adulthood, but in general, onset of FMF after the age of 40 (late onset FMF) is rare, usually associated with M694V heterozygosity. • In a local cluster of FMF families (Altamura, Puglia, Southern Italy), we report a very late-onset FMF (variants E148Q, R761H) in an 86-year-old patient with a positive family history of FMF in two generations of descendants. • While lifetime colchicine remains the mainstay of treatment in FMF patients, prospective studies need to identify the characteristics of several phenotypic variants accounting for (very)-late onset FMF.
Identifiants
pubmed: 31401792
doi: 10.1007/s10067-019-04741-9
pii: 10.1007/s10067-019-04741-9
doi:
Substances chimiques
MEFV protein, human
0
Pyrin
0
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
585-594Références
Bonfrate L, Scaccianoce G, Palasciano G, Ben-Chetrit E, Portincasa P (2017) A novel cluster of patients with familial Mediterranean fever (FMF) in southern Italy. Eur J Clin Investig 47:622–629
doi: 10.1111/eci.12783
Ben-Chetrit E, Touitou I (2009) Familial Mediterranean fever in the world. Arthritis Rheum 61:1447–1453
doi: 10.1002/art.24458
Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, Ozdogan H, Abu I, Gattorno M, Hawkins PN, Yuce S, Kallinich T, Bilginer Y, Kastner D, Carmona L (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75:644–651
doi: 10.1136/annrheumdis-2015-208690
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885
doi: 10.1002/art.1780401023
Portincasa P, Scaccianoce G, Palasciano G (2013) Familial Mediterranean fever: a fascinating model of inherited autoinflammatory disorder. Eur J Clin Investig 43:1314–1327
doi: 10.1111/eci.12170
Moradian MM, Sarkisian T, Ajrapetyan H, Avanesian N (2010) Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations. J Hum Genet 55:389–393
doi: 10.1038/jhg.2010.52
The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90:797–807
doi: 10.1016/S0092-8674(00)80539-5
The French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31
doi: 10.1038/ng0997-25
Bernot A, da Silva C, Petit JL, Cruaud C, Caloustian C, Castet V, Ahmed-Arab M, Dross C, Dupont M, Cattan D, Smaoui N, Dodé C, Pêcheux C, Nédelec B, Medaxian J, Rozenbaum M, Rosner I, Delpech M, Grateau G, Demaille J, Weissenbach J, Touitou I (1998) Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet 7:1317–1325
doi: 10.1093/hmg/7.8.1317
Stella A, Cortellessa F, Scaccianoce G, Pivetta B, Settimo E, Portincasa P (2019) Familial Mediterranean fever: breaking all the (genetic) rules. Rheumatology (Oxford) 58:463–467
doi: 10.1093/rheumatology/key328
Shinar Y, Obici L, Aksentijevich I, Bennetts B, Austrup F, Ceccherini I, Costa JM, de Leener A, Gattorno M, Kania U, Kone-Paut I, Lezer S, Livneh A, Moix I, Nishikomori R, Ozen S, Phylactou L, Risom L, Rowczenio D, Sarkisian T, van Gijn ME, Witsch-Baumgartner M, Morris M, Hoffman HM, Touitou I (2012) Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis 71:1599–1605
doi: 10.1136/annrheumdis-2011-201271
Witsch-Baumgartner M, Touitou I (2015) Clinical utility gene card for: prototypic hereditary recurrent fever syndromes (monogenic autoinflammatory syndromes). Eur J Hum Genet 23:1111
doi: 10.1038/ejhg.2014.257
Tsuchiya-Suzuki A, Yazaki M, Nakamura A et al (2009) Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol 36:1671–1676
doi: 10.3899/jrheum.081278
Van Gijn ME, Ceccherini I, Shinar Y et al (2018) New workflow for classification of genetic variants’ pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID). J Med Genet 55:530–537
doi: 10.1136/jmedgenet-2017-105216
Ozturk C, Halicioglu O, Coker I et al (2012) Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, Turkey. Clin Rheumatol 31:493–501
doi: 10.1007/s10067-011-1876-1
Mattit H, Joma M, Al-Cheikh S et al (2006) Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrier rates and phenotype-genotype correlation. Eur J Med Genet 49:481–486
doi: 10.1016/j.ejmg.2006.03.002
Giaglis S, Papadopoulos V, Kambas K, Doumas M, Tsironidou V, Rafail S, Kartalis G, Speletas M, Ritis K (2007) MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clin Genet 71:458–467
doi: 10.1111/j.1399-0004.2007.00789.x
Cantarini L, Capecchi PL, Lucherini OM, Laghi Pasini F, Galeazzi M (2010) Familial Mediterranean fever diagnosed in an elderly patient. Clin Exp Rheumatol 28:S91
pubmed: 20868579
Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A, Pras M, Pras E (2009) Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 60:1862–1866
doi: 10.1002/art.24570
Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43:227–253
doi: 10.1016/0002-9343(67)90167-2
Sayarlioglu M, Cefle A, Inanc M et al (2005) Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: analysis of 401 cases. Int J Clin Pract 59:202–205
doi: 10.1111/j.1742-1241.2004.00294.x
Tamir N, Langevitz P, Zemer D, Pras E, Shinar Y, Padeh S, Zaks N, Pras M, Livneh A (1999) Late-onset familial Mediterranean fever (FMF): a subset with distinct clinical, demographic, and molecular genetic characteristics. Am J Med Genet 87:30–35
doi: 10.1002/(SICI)1096-8628(19991105)87:1<30::AID-AJMG6>3.0.CO;2-B
Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11
doi: 10.1097/01.md.0000152370.84628.0c
Levy M, Eliakim M (1977) Long-term colchicine prophylaxis in familial Mediterranean fever. Br Med J 2:808
doi: 10.1136/bmj.2.6090.808
Yamane T, Uchiyama K, Hata D, Nakamura M, Ishii T, Koido S, Fujise K, Tajiri H (2006) A Japanese case of familial Mediterranean fever with onset in the fifties. Intern Med 45:515–517
doi: 10.2169/internalmedicine.45.1593
Erten S (2016) Familial Mediterranean fever patient with onset of attacks at the age of seventies. Journal of Clinical and Analytical Medicine 7:109
doi: 10.4328/JCAM.1251
Al-Khafaji J, Ganz-Lord F, Konjeti VR, Viny AD (2018) A case of familial Mediterranean fever with extensive lymphadenopathy and complex heterozygous genotype presenting in the fourth decade. Case Rep Rheumatol 2018:9670801
pubmed: 29808155
pmcid: 5901998
Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Agematsu K, Yachie A, Masumoto J, Migita K, Kawakami A (2018) Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: data from a multicenter, prospective national cohort study in Japan. Arthritis Res Ther 20:257
doi: 10.1186/s13075-018-1738-1
Kishida D, Yazaki M, Nakamura A, Tsuchiya-Suzuki A, Shimojima Y, Sekijima Y (2019) Late-onset familial Mediterranean fever in Japan. Mod Rheumatol:1–4
Aydin O, Ugurlu S, Ozdogan H (2019) THU0590 comparison of FMF patients with age of onset before 20 versus 40 years and over. Ann Rheum Dis 78:586
doi: 10.1136/annrheumdis-2018-214618
Migita K, Agematsu K, Yazaki M, Nonaka F, Nakamura A, Toma T, Kishida D, Uehara R, Nakamura Y, Jiuchi Y, Masumoto J, Furukawa H, Ida H, Terai C, Nakashima Y, Kawakami A, Nakamura T, Eguchi K, Yasunami M, Yachie A (2014) Familial Mediterranean fever: genotype-phenotype correlations in Japanese patients. Medicine (Baltimore) 93:158–164
doi: 10.1097/MD.0000000000000029
Kishida D, Nakamura A, Yazaki M, Tsuchiya-Suzuki A, Matsuda M, Ikeda S (2014) Genotype-phenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations. Arthritis Res Ther 16:439
doi: 10.1186/s13075-014-0439-7
Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351:659–664
doi: 10.1016/S0140-6736(97)09408-7
Korkmaz C, Kasifoglu T (2007) Changes in the liver function tests during the attacks of familial Mediterranean fever. Rheumatol Int 27:395–398
doi: 10.1007/s00296-006-0226-0
Ben-Chetrit E, Yazici H (2017) The liver in familial Mediterranean fever: is it involved? Clin Exp Rheumatol 35:S108–S112
Portincasa P (2016) Colchicine, biologic agents and more for the treatment of familial Mediterranean fever. The old, the new, and the rare. Curr Med Chem 23:60–86
doi: 10.2174/0929867323666151117121706
Grattagliano I, Bonfrate L, Ruggiero V, Scaccianoce G, Palasciano G, Portincasa P (2014) Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics. Clin Pharmacol Ther 95:89–97
doi: 10.1038/clpt.2013.148
Wang D, Bonfrate L, de Bari O, Wang T, Portincasa P (2014) Familial Mediterranean fever: from pathogenesis to treatment. J Genet Syndr Gene Ther 5:2
Federici S, Sormani MP, Ozen S, Lachmann HJ, Amaryan G, Woo P, Koné-Paut I, Dewarrat N, Cantarini L, Insalaco A, Uziel Y, Rigante D, Quartier P, Demirkaya E, Herlin T, Meini A, Fabio G, Kallinich T, Martino S, Butbul AY, Olivieri A, Kuemmerle-Deschner J, Neven B, Simon A, Ozdogan H, Touitou I, Frenkel J, Hofer M, Martini A, Ruperto N, Gattorno M, for the Paediatric Rheumatology International Trials Organisation (PRINTO) and Eurofever Project (2015) Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis 74:799–805
doi: 10.1136/annrheumdis-2014-206580
Yenokyan G, Armenian HK (2012) Triggers for attacks in familial Mediterranean fever: application of the case-crossover design. Am J Epidemiol 175:1054–1061
doi: 10.1093/aje/kwr460